Blog
59 Articles
A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.
A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.
More Effective Treatment for Metastatic Pancreatic Cancer
A worldwide clinical trial is testing a new drug combined with standard treatment, for patients with metastatic pancreatic cancer.
Pancreatic Cancer Research Updates from ASCO 2024
Learn about the latest developments in pancreatic cancer research into immunotherapy and chemotherapy from the ASCO 2024 meeting.
A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
Using Ultrasound to Enhance the Effectiveness of Chemotherapy
A clinical trial combines ultrasound with a microbubble contrast agent to make chemotherapy more effective.
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
A New Approach to Immunotherapy for Advanced Pancreatic Cancer
Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.
Using Ice to Prevent Neuropathy
Neuropathy–tingling or numbness in your extremities–is a common side effect of chemotherapy. Learn more about the role of ice in preventing neuropathy.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
More Research Needed For Neuropathy
Dr. Allyson Ocean discusses the use of glutamine to ease the neuropathy caused by chemotherapy drugs for pancreatic cancer.